{"organizations": [], "uuid": "84caf96775771f8b54b5fb00e2741b9ea5c4f369", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "http://si.wsj.net/public/resources/images/BN-KA833_0827li_G_20150827112151.jpg", "site_section": "http://www.wsj.com/news/world/asia", "section_title": "Asia Business, Finance &amp; Political News - The Wall Street Journal", "url": "http://www.wsj.com/articles/eli-lilly-and-chinas-innovent-expand-partnership-1444647178", "country": "US", "title": "Eli Lilly and China’s Innovent Expand Partnership", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "Eli Lilly and China’s Innovent Expand Partnership - WSJ", "spam_score": 0.0, "site_type": "news", "published": "2015-10-12T14:52:00.000+03:00", "replies_count": 0, "uuid": "84caf96775771f8b54b5fb00e2741b9ea5c4f369"}, "author": "Ezequiel Minaya", "url": "http://www.wsj.com/articles/eli-lilly-and-chinas-innovent-expand-partnership-1444647178", "ord_in_thread": 0, "title": "Eli Lilly and China’s Innovent Expand Partnership", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Eli Lilly & Co. and Innovent Biologics Inc. said late Sunday that they have expanded their collaboration deal and defined the distribution rights for up to three co-developed, experimental cancer drugs.\nAccording to a joint statement, Eli Lilly would market the drugs outside of China with Innovent marketing the drugs inside the Asian country, subject to a Lilly opt-in right.\nUnder the expanded agreement, Innovent could... ", "external_links": [], "published": "2015-10-12T14:52:00.000+03:00", "crawled": "2015-10-12T14:19:26.999+03:00", "highlightTitle": ""}